Table 1.
Characteristics | Overall population n = 430 (%) |
---|---|
Age at ICI start | |
Median (range) | 69.0 (32.0-92.0) |
Sex | |
Female | 142 (33.0%) |
Male | 288 (67.0%) |
Smoking status | |
Current/former | 248 (57.0%) |
Never | 169 (39%) |
NA | 13 (4.0%) |
Tumor type | |
NSCLC | 266 (62.0%) |
RCC | 74 (17.0%) |
Melanoma | 55 (13.0%) |
Others* | 35 (8.0%) |
Treatment type | |
ICI | 373 (87.0%) |
ICI plus chemotherapy | 27 (6.0%) |
ICI plus TKI | 30 (7.0%) |
Treatment line | |
First | 235 (55.0%) |
≥ second | 195 (45.0%) |
ECOG PS | |
0-1 | 385 (89.0%) |
≥2 | 45 (10.0%) |
Metastatic sites | |
0-1 | 103 (24.0%) |
≥2 | 327 (76.0%) |
Diagnosis of DM | |
No | 346 (81.0%) |
Yes | 84 (19.0%) |
CV disease | |
No | 293 (68.0%) |
Yes | 135 (31.0%) |
NA | 2 (1.0%) |
Hypertension | |
No | 189 (44.0%) |
Yes | 241 (56.0%) |
Statin use | |
No | 312 (72.0%) |
Yes | 115 (27.0%) |
NA | 3 (1.0%) |
BMI | |
Underweight (BMI < 18.5) |
18 (4.2%) |
Normal (18.5 ≤ BMI ≤ 24.9) |
213 (49.5%) |
Overweight (25 ≤ BMI ≤ 29.9) |
135 (31.4%) |
Obese (BMI ≥ 30) |
60 (13.9%) |
NA | 4 (0.9%) |
TC | |
<200 mg/dl | 295 (69.0%) |
≥200 mg/dl | 135 (31.0%) |
HDL | |
< 40 mg/dl (males) or < 50 mg/dl (females) | 92 (21.0%) |
≥ 40 mg/dl (males) or ≥ 50 mg/dl (females) | 167 (39.0%) |
NA | 171 (40.0%) |
LDL | |
< 100 mg/dl | 150 (35.0%) |
≥ 100 mg/dl | 107 (25.0%) |
NA | 173 (40.0%) |
TG | |
<150 mg/dl | 220 (52.0%) |
≥150 mg/dl | 96 (22.0%) |
NA | 114 (26.0%) |
*Others: urothelial carcinoma, head and neck carcinoma, small cell lung cancer, and breast cancer
Abbreviations: HDL: high-density cholesterol; LDL: low-density cholesterol; ICI: immune checkpoint inhibitor; NSCLC: non-small cell lung cancer; RCC: renal cell carcinoma; TKI: tyrosine kinase inhibitor; ECOG PS: Eastern Cooperative Oncology Group-Performance Status; DM: diabetes mellitus; BMI: body mass index (kg/m2); NA: not available; TC: total cholesterol; TG: triglycerides.